Overview Preoperative Bevacizumab for Vitreous Hemorrhage Status: Completed Trial end date: 2008-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether preoperative intravitreal bevacizumab is effective in reducing intra-operative and postoperative bleeding in diabetic patients submitted to pars plana vitrectomy for vitreous hemorrhage. Phase: Phase 1/Phase 2 Details Lead Sponsor: University of Sao PauloTreatments: BevacizumabTemazepam